ID | Term | Allele | Alleles | Background | Color Key |
---|
MP:0000639 | abnormal adrenal gland morphology |
Mc2rtm1Dchi |
Mc2rtm1Dchi/Mc2rtm1Dchi | B6.129P2-Mc2r | color key |
MP:0003383 | abnormal gluconeogenesis |
Mc2rtm1Dchi |
Mc2rtm1Dchi/Mc2rtm1Dchi | B6.129P2-Mc2r | color key |
MP:0002078 | abnormal glucose homeostasis |
Mc2rtm1Dchi |
Mc2rtm1Dchi/Mc2rtm1Dchi | B6.129P2-Mc2r | color key |
MP:0008299 | adrenal cortical hyperplasia |
Mc2rtm1Dgen |
Mc2rtm1Dgen/Mc2rtm1Dgen | involves: 129P2/OlaHsd * C57BL/6J | color key |
MP:0000640 | adrenal gland hypoplasia |
Mc2rtm1Dchi |
Mc2rtm1Dchi/Mc2rtm1Dchi | B6.129P2-Mc2r | color key |
MP:0000640 | adrenal gland hypoplasia |
Mc2rtm1Dgen |
Mc2rtm1Dgen/Mc2rtm1Dgen | involves: 129P2/OlaHsd * C57BL/6J | color key |
MP:0009137 | decreased brown fat lipid droplet number |
Mc2rtm1Dgen |
Mc2rtm1Dgen/Mc2rtm1Dgen | involves: 129P2/OlaHsd * C57BL/6J | color key |
MP:0005661 | decreased circulating adrenaline level |
Mc2rtm1Dchi |
Mc2rtm1Dchi/Mc2rtm1Dchi | B6.129P2-Mc2r | color key |
MP:0002667 | decreased circulating aldosterone level |
Mc2rtm1Dchi |
Mc2rtm1Dchi/Mc2rtm1Dchi | B6.129P2-Mc2r | color key |
MP:0002665 | decreased circulating corticosterone level |
Mc2rtm1Dchi |
Mc2rtm1Dchi/Mc2rtm1Dchi | B6.129P2-Mc2r | color key |
MP:0005333 | decreased heart rate |
Mc2rtm1Dchi |
Mc2rtm1Dchi/Mc2rtm1Dchi | B6.129P2-Mc2r | color key |
MP:0005459 | decreased percent body fat |
Mc2rtm1Dgen |
Mc2rtm1Dgen/Mc2rtm1Dgen | involves: 129P2/OlaHsd * C57BL/6J | color key |
MP:0010025 | decreased total body fat amount |
Mc2rtm1Dchi |
Mc2rtm1Dchi/Mc2rtm1Dchi | B6.129P2-Mc2r | color key |
MP:0001399 | hyperactivity |
Mc2rtm1Dgen |
Mc2rtm1Dgen/Mc2rtm1Dgen | involves: 129P2/OlaHsd * C57BL/6J | color key |
MP:0000189 | hypoglycemia |
Mc2rtm1Dchi |
Mc2rtm1Dchi/Mc2rtm1Dchi | B6.129P2-Mc2r | color key |
MP:0001363 | increased anxiety-related response |
Mc2rtm1Dgen |
Mc2rtm1Dgen/Mc2rtm1Dgen | involves: 129P2/OlaHsd * C57BL/6J | color key |
MP:0001748 | increased circulating adrenocorticotropin level |
Mc2rtm1Dchi |
Mc2rtm1Dchi/Mc2rtm1Dchi | B6.129P2-Mc2r | color key |
MP:0003019 | increased circulating chloride level |
Mc2rtm1Dchi |
Mc2rtm1Dchi/Mc2rtm1Dchi | B6.129P2-Mc2r | color key |
MP:0005627 | increased circulating potassium level |
Mc2rtm1Dchi |
Mc2rtm1Dchi/Mc2rtm1Dchi | B6.129P2-Mc2r | color key |
MP:0004952 | increased spleen weight |
Mc2rtm1Dchi |
Mc2rtm1Dchi/Mc2rtm1Dchi | B6.129P2-Mc2r | color key |
MP:0002906 | increased susceptibility to pharmacologically induced seizures |
Mc2rtm1Dgen |
Mc2rtm1Dgen/Mc2rtm1Dgen | involves: 129P2/OlaHsd * C57BL/6J | color key |
MP:0004955 | increased thymus weight |
Mc2rtm1Dchi |
Mc2rtm1Dchi/Mc2rtm1Dchi | B6.129P2-Mc2r | color key |
MP:0005202 | lethargy |
Mc2rtm1Dchi |
Mc2rtm1Dchi/Mc2rtm1Dchi | B6.129P2-Mc2r | color key |
MP:0011086 | partial postnatal lethality |
Mc2rtm1Dchi |
Mc2rtm1Dchi/Mc2rtm1Dchi | B6.129P2-Mc2r | color key |